(2020) designed 23-mer (A2N)-CHIPΔTPR fusion, and this ACE2-derived peptide demonstrated robust RBD degradation capabilities in human cells and reduced the infection rate of the pseudovirus by ~60% (Chatterjee et al., 2020). Here, ACE2 is linked to infection.